U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,519 records

Showing results for "randomized controlled trial".

  1. Disposition of Comments_Technical Brief No. 45: Long COVID Models of Care (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-disposition-comments.pdf
    January 01, 2022 - syndrome with unknown mechanisms and pathophysiology, optimal treatment is unclear and can involve the trial … Randomized Controlled Trials, other Research Demonstrate the Effectiveness of Primary Care Behavioral

  2. Making Healthcare Safer IV: Summary of Findings on Patient Safety Practices and Ratings by a Technical Expert Panel, 2024-2025 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-patient-safety-practices-year-2.pdf
    May 01, 2025 - o 2 systematic reviews and 13 studies (4 randomized controlled trials (RCT) and 9 pre- post) that examined

  3. Disposition of Comments for Quality Improvement Interventions To Address Health Disparities (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
    August 27, 2012 - For example, a program to improve mental health care that was a randomized trial involving only black

  4. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
    December 11, 2012 - There is an ongoing prospective clinical trial regarding timing of orchiopexy: Kollin C, Karpe B, Hesser … Fertility- No mention to the age of orchidopexy which is not controlled in respect to semen parameters

  5. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
    June 30, 2015 - Disposition of Comments for Technical Brief 23 Genetic Testing Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder Draft review available for public comment from Dec…

  6. Evidence Summary-Comparative-Effectiveness-Review-213-Lower-Limb-Prostheses (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-213-lower-limb-protheses-evidence-summary.pdf
    September 01, 2018 - Only one of the eligible studies was a randomized trial, but it evaluated atypical, nonvalidated predictor

  7. Disposition of Comments for CER 158 Diagnosis of Gout (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
    February 24, 2016 - specific here … something along the lines of “failure to diagnose gout was reported in a single-center trial

  8. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized … Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … intention-to-treat; NA = not applicable; NPP = neuropathic pain; NR = not reported; PP = per protocol; RCT = randomized … controlled trial; THC = tetrahydrocannabinol.

  9. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - Are you trying to make a point about what variables were controlled for? … The point here is that pre-visit “baseline health” was controlled for, not post-visit. … Affiliation Section Comment Response TEP Member 5 Results The authors are probably aware of the trial

  10. Appendix-E-Evidence-Tables-E1-E4 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
    May 29, 2025 - Duration Measure (Mean, Median) Pain Duration, months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … human immunodeficiency virus; NA = not applicable; NPP = neuropathic pain; NR = not reported; RCT = randomized … controlled trial; THC = tetrahydrocannabinol; U.S. = United States Table E-1.

  11. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized … Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … intention-to-treat; NA = not applicable; NPP = neuropathic pain; NR = not reported; PP = per protocol; RCT = randomized … controlled trial; THC = tetrahydrocannabinol.

  12. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized … Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … intention-to-treat; NA = not applicable; NPP = neuropathic pain; NR = not reported; PP = per protocol; RCT = randomized … controlled trial; THC = tetrahydrocannabinol.

  13. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized … Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … intention-to-treat; NA = not applicable; NPP = neuropathic pain; NR = not reported; PP = per protocol; RCT = randomized … controlled trial; THC = tetrahydrocannabinol.

  14. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … human immunodeficiency virus; NA = not applicable; NPP = neuropathic pain; NR = not reported; RCT = randomized … controlled trial; THC = tetrahydrocannabinol.

  15. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … human immunodeficiency virus; NA = not applicable; NPP = neuropathic pain; NR = not reported; RCT = randomized … controlled trial; THC = tetrahydrocannabinol.

  16. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    May 29, 2025 - Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … human immunodeficiency virus; NA = not applicable; NPP = neuropathic pain; NR = not reported; RCT = randomized … controlled trial; THC = tetrahydrocannabinol; U.S. = United States Table E-1.

  17. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized … Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … Patient-Reported Outcomes Measurement Information System PSQI Pittsburg Sleep Quality Index RCT randomized … controlled trial SD standard deviation SE standard error SF-36 Short-form 36 Item Survey SF-MPQ

  18. Disposition of Comments_Technical Brief No. 47: Measuring Documentation Burden in Healthcare (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-prepub-disposition-comments.pdf
    May 21, 2024 - This randomized controlled trial studied time-sensitive alerts, clinical notifications delivered to

  19. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized … Duration Measure (Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid Use at Baseline N Randomized … Patient-Reported Outcomes Measurement Information System PSQI Pittsburg Sleep Quality Index RCT randomized … controlled trial SD standard deviation SE standard error SF-36 Short-form 36 Item Survey SF-MPQ
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites